Alaunos Therapeutics Inc (TCRT) stock news · rev $5.0K
Alaunos Therapeutics Inc (TCRT) is a biotechnology company listed on NASDAQ.
This TCRT news page leads with what Alaunos Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for TCRT yet. We will not pad this page with generic market recap.
Latest reported TCRT revenue for 2025-12-31 was $5.0K. Net income was -$4.2M. Revenue was down 50.0% from 2024-12-31 to 2025-12-31. TCRT currently screens at market cap $5.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TCRT stock page; for the tape open the quote page.
TCRT stock news FAQ
What are TCRT's latest revenue and net income?
Latest cached Alaunos Therapeutics Inc (TCRT) revenue for Dec 31, 2025 was $5.0K. Net income was -$4.2M. Statements: https://lician.com/financials/tcrt
How did TCRT revenue change from the prior cached period?
Cached Alaunos Therapeutics Inc (TCRT) revenue was down 50.0% from $10.0K (Dec 31, 2024) to $5.0K (Dec 31, 2025). Statements: https://lician.com/financials/tcrt
What is TCRT's market cap?
Alaunos Therapeutics Inc (TCRT) market cap is $5.6M on the latest cached fundamentals snapshot.
What kind of company is TCRT?
Alaunos Therapeutics Inc (TCRT) is a biotechnology company listed on NASDAQ.
Where is TCRT stock news listed?
Cached stock news for Alaunos Therapeutics Inc (TCRT) is listed at https://lician.com/news/tcrt. Filings: https://lician.com/sec/tcrt
Not investment advice.